ZYBERNO
Stock Report
Updated Aug 28, 2026

CENTENE CORPORATION (CNC)

Healthcare • NYSE

$65.33
Centene Corporation is an American multinational managed care company headquartered in St. Louis, Missouri, and one of the largest Medicaid managed care organizations in the United States. The company provides government-sponsored and commercial healthcare programs to under-insured and uninsured individuals through Medicaid managed care, Medicare, and commercial health insurance marketplace plans, as well as specialty services including pharmacy benefits management and behavioral health.

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
39.0/100
WEAK BUSINESS
CENTENE CORPORATION (CNC) scores 39/100 — weak fundamentals with mixed indicators requiring careful analysis before acting.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
MARGIN OF SAFETY
Is this stock cheap or expensive relative to what the business has historically generated for owners?
-1.7%
Fairly Valued
Growth gap unavailable — insufficient data for reverse DCF calculation.
🎯 Expected Annual Return
-20.3%
Margin of Safety convergence — your return if the market re-prices to intrinsic value (5-yr annualised)
2.0%
Yield + growth — what the business alone earns you, even if the market never re-rates
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-23.9%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.09x)
Operating Margin (Operational Efficiency):CRITICAL (-2.8%)
Return on Capital (Capital Efficiency):CRITICAL (-12.7%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

CENTENE CORPORATION (CNC) stock report — Zyberno Score 39/100 (WEAK BUSINESS), Margin of Safety -1.7%, -20% expected annual return. Full financial analysis on Zyberno.

According to Zyberno's DCF model, CENTENE CORPORATION (CNC) trades at $65.33 against an estimated intrinsic value per share of $64.23 — a -1.7% Margin of Safety based on Owner Earnings of $7.11B TTM, projected at -24.9% growth for 10 years with a 2.5% terminal growth rate. Zyberno's model translates this into a 5-year expected return of -20.3% annually.

Over the trailing twelve months, CNC generated $7.11B in Owner Earnings. Capital was deployed as follows: $29.00M returned via share buybacks, $832.00M invested in capital expenditures. Reinvestment rate: 158.6%. Owner Earnings have declined at 24.9% annually over the trailing five years using log-linear regression.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:65.33
Market Cap:$32.26B

Valuation Multiples (3)

P/B Ratio:1.43x
P/S Ratio:0.16x
Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$42.11B
Pfcf Ratio:4.54x

Price Action & Momentum (2)

B. Profitability Assessment

Return Metrics (5)

ROA:-6.3%
Reinvestment Rate:158.6%
Fundamental Growth Rate (g):-20.2%

Margin Analysis (3)

Operating Margin Ttm:-2.8%
Net Margin Ttm:-2.5%
Ebitda Margin:-1.9%

TTM Performance (3)

Gross Margin Ttm:8.0%
Operating Margin Ttm:-2.8%
Net Margin Ttm:-2.5%

Yield Metrics (3)

Earnings Yield:-$15.84
Owner Earnings Yield:$22.05
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:247.6%
Latest Earnings Filed:2026-07-28

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):11.4%

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):21.9%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):-24.9%
Operating Cash Flow Growth Rate (Linear):-16.7%

Operating Growth (Linear) (1)

Operating Income Growth Rate (Linear):10.6%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.15x
Quick Ratio:1.15x
Cash Ratio:0.59x

Leverage Analysis (3)

Debt To Equity Ttm:0.09x
Debt-to-Equity Ratio:0.09x
Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-11.64x
Times Interest Earned:-11.64

Capital Structure (4)

Working Capital:5,926,000,000.00
Cash And Cash Equivalents:24,151,000,000.00
Long Term Debt:$16.03B
Net Debt:$9.84B
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $202.94B
Linear Growth: 11.4%
📊 Click to view full CNC Revenue analysis & methodology →
Cost Of Revenue Ttm:$2.76B

Profitability Breakdown (2)

Gross profit TTM: $16.17B
Linear Growth: -5.0%
📊 Click to view full CNC Gross Profit analysis & methodology →
Operating income TTM: -$5.64B
Linear Growth: 10.6%
📊 Click to view full CNC Operating Income analysis & methodology →

Bottom Line Performance (3)

Net income TTM: -$5.10B
Linear Growth: 21.9%
📊 Click to view full CNC Net Income analysis & methodology →
Income Before Tax:-$4.63B
Ebitda Ttm:-3,878,000,000.00

Operating Expenses (5)

Operating Expenses:208,578,000,000.00
R And D Expense:0.00
Sga Expense:13,015,000,000.00
Income Tax Expense:$474.00M
Interest Expense:655,000,000.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:24.3%
Ebitda Margin:-1.9%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$83.01B
Current Assets:$46.69B
Ppe Net:2,130,000,000.00
Goodwill:10,835,000,000.00
Intangible Assets:$4.20B

Liability Structure (4)

Total Liabilities:60,355,000,000.00
Current Liabilities:40,759,000,000.00
Long Term Debt:$16.03B
Short Term Debt:$17.97B

Equity & Capital (3)

Equity:$22.63B
Retained Earnings:$11.31B
Common Stock:800,000,000.00

Working Capital Items (3)

Accounts Receivable:0.00
Inventory:0.00
Accounts Payable:17,965,000,000.00

Special Items (2)

Contract Liabilities:706,000,000.00
Stock Based Compensation:67,000,000.00
C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: $7.94B
Linear Growth: -16.7%
Free cash flow TTM: $7.11B
Linear Growth: -24.9%
📊 Click to view full CNC Free Cash Flow analysis & methodology →

Investment Activities (2)

Investing Cash Flow:$89.00M
Capital Expenditures Ttm:832,000,000.00

Financing Activities (3)

Financing Cash Flow:-$1.06B
Dividends Paid Ttm:0.00
Stock Repurchase:29,000,000.00

Capital Transactions (3)

Common Stock Issuance:10,000,000.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$1.05B

Non-Cash Items (1)

Depreciation Amortization Ttm:1,762,000,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-10.32
Eps diluted TTM: -$10.35
Linear Growth: 26.9%
📊 Click to view full CNC EPS analysis & methodology →
Earnings Per Share Ttm:-$10.33

Revenue & Cash Per Share (3)

Sales Per Share Ttm:410.96
Operating Cash Flow Per Share:$10.30
Fcf Per Share Ttm:14.40

Book Value & Capital (2)

Book Value Per Share:$45.83
Cash Per Share:48.91

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:2.51x
Working Capital Turnover Ttm:34.25x

Receivables Management (2)

Receivables Turnover Ttm:-999.00x
Days Sales Outstanding Ttm:-999.00

Inventory Management (2)

Inventory Turnover Ttm:-999.00x
Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:2,374.09
Cash Conversion Cycle:-4,372.09
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:40.00
Quality Score:35.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (3)

Owner earnings TTM: $7.11B
Linear Growth: -24.9%
📊 Click to view full CNC Owner Earnings analysis & methodology →
Owner Earnings Per Share:$14.40
Owner Earnings Yield:$22.05

Growth Assessment (1)

Owner Earnings Growth Rate:-$24.92

Damodaran Growth Analysis (2)

Reinvestment Rate:158.6%
Fundamental Growth Rate (g):-20.2%

Intrinsic Value Models (1)

Margin of Safety (1)

Return Scenarios (2)

Investment Assessment (1)

Buffett Assessment:Overvalued
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (3)

Revenue Growth Rate (Linear):11.4%
Net Income Growth Rate (Linear):21.9%
Operating Income Growth Rate (Linear):10.6%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):-24.9%
Operating Cash Flow Growth Rate (Linear):-16.7%

Other Growth Rates (3)

Gross Profit Growth Rate (Linear):-5.0%
Book Value Growth Rate (Linear):-4.3%
Owner Earnings Growth Rate:-$24.92
C. Company Profile & Context

Corporate Information (6)

Symbol:CNC
Company Name:CENTENE CORPORATION
Sector:Healthcare
Industry:Healthcare Services
Exchange:NYSE
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:high
Volume Category:N/A

Share Structure (3)

Shares Outstanding:493.82M
Shares Outstanding Basic:493.82M
Shares Outstanding Diluted:497.64M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-28 19:04:55 UTC
Data Timestamp:2026-08-28T19:04:55.868073
Scroll to Top